⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for leukemia, acute myelogenous (aml)

Every month we try and update this database with for leukemia, acute myelogenous (aml) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDSNCT03291444
Leukemia, Acute...
Leukemia, Acute...
Myelodysplastic...
Chimeric antige...
peptide specifi...
18 Years - 80 YearsZhujiang Hospital
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the BloodNCT00923910
Leukemia, Acute...
Leukemia, Acute...
Leukemia, Chron...
Myelodysplastic...
Non-Hodgkin's L...
WT1 Peptide-Pul...
Donor Lymphocyt...
IL-4
KLH
WT1 Peptides
Endotoxin
Diphenhydramine
Acetaminophen
1 Year - 74 YearsNational Institutes of Health Clinical Center (CC)
CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDSNCT03291444
Leukemia, Acute...
Leukemia, Acute...
Myelodysplastic...
Chimeric antige...
peptide specifi...
18 Years - 80 YearsZhujiang Hospital
CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDSNCT03291444
Leukemia, Acute...
Leukemia, Acute...
Myelodysplastic...
Chimeric antige...
peptide specifi...
18 Years - 80 YearsZhujiang Hospital
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: